Revestive approved in Europe for pediatric patients with short bowel syndrome July 7, 2016 No Comments
FDA approves Epclusa as pan-genotypic single-tablet regimen for chronic HCV infection June 29, 2016 No Comments
European Commission approves Avastin plus Tarceva for advanced NSCLC with EGFR-activating mutations June 9, 2016 No Comments
RSS